However, the early administration was not associated with improved patency of the IRA pre-PCI but showed a trend toward reducing adverse ischemic events post-PCI.
← all excerpts
Current and Future Insights for Optimizing Antithrombotic Therapy to Reduce the Burden of Cardiovascular Ischemic Events in Patients with Acute Coronary Syndrome.
1
—
—